Sandy Spring Bank Compass Pathways PLC Transaction History

Sandy Spring Bank

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 21, 2022	SELL	$6.76 - $14.18 $3,042 - $6,381	-450 Reduced 63.56%	258 $3,000
Q1 2022 May 03, 2022	SELL	$11.13 - $23.04 $17,808 - $36,864	-1,600 Reduced 69.32%	708 $9,000
Q4 2021 Feb 11, 2022	BUY	$21.81 - $48.96 $3,053 - $6,854	140 Added 6.46%	2,308 $51,000
Q3 2021 Nov 05, 2021	BUY	$29.03 - $38.62 $1,974 - $2,626	68 Added 3.24%	2,168 $65,000
Q2 2021 Aug 09, 2021	BUY	$32.29 - $39.68 $51,664 - $63,488	1,600 Added 320.0%	2,100 $80,000
Q1 2021 May 03, 2021	BUY	$34.75 - $57.5 $10,425 - $17,250	300 Added 150.0%	500 $18,000
Q4 2020 Feb 03, 2021	BUY	$32.0 - $59.2 $6,400 - $11,840	200 New	200 $10,000

152

33.6M

536K

582K

Ticker CMPS
Exchange NASDAQ
Sector Healthcare
Industry Medical Care Facilities
Shares Outstandng 42,522,400
Market Cap $363M
Description
COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder. Th...

Get notified when there are updates to the investment portfolio of Sandy Spring Bank, based on Form 13F filings with the SEC.

Stay updated on Sandy Spring Bank with notifications on news.